Meruvax II Side Effects
Generic Name: rubella virus vaccine
Note: This document contains side effect information about rubella virus vaccine. Some of the dosage forms listed on this page may not apply to the brand name Meruvax II.
For the Consumer
Applies to rubella virus vaccine: subcutaneous injectable, subcutaneous powder for solution
Along with its needed effects, rubella virus vaccine (the active ingredient contained in Meruvax II) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking rubella virus vaccine:
Symptoms of allergic reaction
- Difficulty in breathing or swallowing
- itching, especially of feet or hands
- reddening of skin, especially around ears
- swelling of eyes, face, or inside of nose
- unusual tiredness or weakness (sudden and severe)
Check with your doctor as soon as possible if any of the following side effects occur while taking rubella virus vaccine:
- Pain or tenderness of eyes
- Bruising or purple spots on skin
- convulsions (seizures)
- headache (severe or continuing)
- pain, numbness, or tingling of hands, arms, legs, or feet
- stiff neck
- unusual irritability
Some side effects of rubella virus vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Burning or stinging at place of injection
- skin rash
- swelling of glands in neck
- Aches or pain in joints
- headache (mild), sore throat, runny nose, or fever
- itching, swelling, redness, tenderness, or hard lump at place of injection
- vague feeling of bodily discomfort
The above side effects (especially aches or pain in joints) are more likely to occur in adults, particularly women.
Some of the above side effects may not occur until 1 to 4 weeks after immunization and usually last less than 1 week. Aches or pain in joints may not occur until 1 to 10 weeks after immunization, and usually lasts less than 1 week. Check with your doctor if this side effect continues or is bothersome.
For Healthcare Professionals
Applies to rubella virus vaccine: subcutaneous powder for injection
The vaccine has rarely been associated with chronic joint symptoms. The incidence of arthritis and arthralgia is generally higher in adult women than in children (women, 12% to 26%; children, 0% to 3%), and symptoms tend to be more marked and of longer duration, persisting for months or years (rare). In adolescent girls, the incidence of reactions appears to be intermediate between those seen in children and in women. These reactions are generally well tolerated and rarely interfere with normal activities, even in women over 35 years old.[Ref]
Musculoskeletal side effects have included arthralgia and/or arthritis (usually transient and rarely chronic), myalgia, paresthesia, and rarely chronic arthritis; these symptoms may also occur with natural rubella.[Ref]
Respiratory side effects have included sore throat, cough, and rhinitis.[Ref]
Other side effects have included fever, syncope, headache, dizziness, malaise, and irritability. Fatalities have been reported with the polyvalent measles/mumps/rubella vaccine; however, causality has not been determined.
Health care providers should report any allergic or unusual adverse reactions to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 (USA) and the manufacturer.[Ref]
1. "Product Information. Meruvax II (rubella virus vaccine, live)." Merck & Co, Inc, West Point, PA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.